Related Experiment Video
Updated: Jul 10, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter
Dmitrii S Traktirov1, Ilya R Nazarov2, Valeria S Artemova1,3
1Department of Physiology (Pavlov's), Institute of Experimental Medicine, 197022 St. Petersburg, Russia.
Altering dopamine transporter (DAT) gene function profoundly disrupts dopamine and serotonin neurotransmission across the brain and spinal cord. This highlights potential interactions between dopaminergic and serotonergic systems, crucial for drug therapy.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Dopamine (DA) and serotonin (5-HT) are key monoaminergic neurotransmitters in the central nervous system (CNS).
- Their roles in normal function and diseases like Parkinson's and depression are extensively studied.
- The dopamine transporter (DAT) regulates dopamine signaling.
Purpose of the Study:
- To investigate the effects of DAT gene knockout on neurotransmission.
- To examine the impact on both dopamine and serotonin systems.
- To assess implications for pharmacotherapy targeting dopaminergic drugs.
Main Methods:
- Utilized a knockout model lacking the gene for the dopamine transporter (DAT).
- Analyzed dopamine neurotransmission in various brain regions and the spinal cord.
- Measured mRNA expression of monoamine metabolism enzymes and tissue serotonin levels.
Main Results:
- DAT gene knockout caused significant dopamine dysregulation in multiple CNS regions.
- Alterations in mRNA expression of monoamine metabolism enzymes were observed.
- Serotonin levels were notably changed, particularly in the cerebellum and spinal cord.
Conclusions:
- Region-specific changes in serotonin and enzyme expression indicate complex DA-5HT interactions.
- Modulating the dopaminergic system can significantly impact the serotonergic system.
- These findings are critical for predicting therapeutic and side effects of dopaminergic drugs.
More Related Videos
09:54Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Antidepressant Drugs: MAOIs and Other Agents
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...